Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID-
19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April …

The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …

Introduction: COVID-19 vaccines became available after being carefully monitored in clinical
trials with safety and efficacy on the human body. However, a few recipients developed …

Severe coronavirus (SARS-COV-2) infection often leads to systemic inflammation
accompanied by cardiovascular complications including venous thromboembolism (VTE) …

Since the beginning of the COVID-19 (Coronavirus Disease of 2019) pandemic, myocarditis
has received much attention and controversy as one of the more worrisome cardiovascular …

Endomyocardial biopsy as the cornerstone of diagnostics has been re-evaluated throughout
the years, leaving unanswered questions on the precedence of it. The reported incidence of …

Despite the progress of its management, COVID-19 maintains an ominous condition which
constitutes a threat, especially for the susceptible population. The cardiac injury occurs in …

A novel coronavirus emerged in China in late 2019 as a disease named coronavirus
disease 2019. This pathogen was initially identified as causing a respiratory syndrome, but …

Abstract Introduction: COVID-19, the infectious disease caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), often presents with a spectrum of symptoms at …

The emergence of the novel SARS-CoV-2 virus in late 2019 introduced new, unpreceded
global challenges. Complications arising from COVID-19 widely range from mild to severe …